Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Evoke Pharma stock

Learn how to easily invest in Evoke Pharma stock.

Evoke Pharma Inc
+ $0.20 ( + 6.51%)

Evoke Pharma Inc is a drug manufacturers-specialty & generic business based in the US. Evoke Pharma shares (EVOK) are listed on the NASDAQ and all prices are listed in US Dollars. Evoke Pharma employs 4 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Evoke Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EVOK – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Evoke Pharma stock price (NASDAQ: EVOK)

Use our graph to track the performance of EVOK stocks over time.

Evoke Pharma shares at a glance

Information last updated 2022-07-02.
Latest market close$3.07
52-week range$2.03 - $18.96
50-day moving average $3.72
200-day moving average $7.87
Wall St. target price$78.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.99

Buy Evoke Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Evoke Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Evoke Pharma price performance over time

Historical closes compared with the close of $3.07 from 2022-07-05

1 week (2022-06-30) -5.25%
1 month (2022-06-07) 32.33%
3 months (2022-04-05) 642.98%
6 months (2022-01-06) 479.35%
1 year (2021-07-07) 157.98%
2 years (2020-07-07) -15.43%
3 years (2019-07-05) 348.11%
5 years (2017-07-06) 17.18%

Evoke Pharma financials

Revenue TTM $1.9 million
Gross profit TTM $1.3 million
Return on assets TTM -33.6%
Return on equity TTM -166.36%
Profit margin 0%
Book value $0.71
Market capitalisation $10.8 million

TTM: trailing 12 months

Evoke Pharma share dividends

We're not expecting Evoke Pharma to pay a dividend over the next 12 months.

Have Evoke Pharma's shares ever split?

Evoke Pharma's shares were split on a 1:12 basis on 22 May 2022. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Evoke Pharma shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Evoke Pharma shares which in turn could have impacted Evoke Pharma's share price.

Evoke Pharma share price volatility

Over the last 12 months, Evoke Pharma's shares have ranged in value from as little as $2.03 up to $18.96. A popular way to gauge a stock's volatility is its "beta".

EVOK.US volatility(beta: 0.78)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evoke Pharma's is 0.7763. This would suggest that Evoke Pharma's shares are less volatile than average (for this exchange).

Evoke Pharma overview

Evoke Pharma, Inc. , a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. .

Frequently asked questions

What percentage of Evoke Pharma is owned by insiders or institutions?
Currently 2.464% of Evoke Pharma shares are held by insiders and 5.002% by institutions.
How many people work for Evoke Pharma?
Latest data suggests 4 work at Evoke Pharma.
When does the fiscal year end for Evoke Pharma?
Evoke Pharma's fiscal year ends in December.
Where is Evoke Pharma based?
Evoke Pharma's address is: 420 Stevens Avenue, Solana Beach, CA, United States, 92075
What is Evoke Pharma's ISIN number?
Evoke Pharma's international securities identification number is: US30049G2030
What is Evoke Pharma's CUSIP number?
Evoke Pharma's Committee on Uniform Securities Identification Procedures number is: 30049G104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site